NCR1 and acute myeloid leukemia: NK cells from patients with AML often express low levels of NKp46 at diagnosis35, but induction chemotherapies can restore NK cell function and normal NKp46 expression36, and high levels of NKp46 at the cell surface correlate with better outcomes in allogeneic stem cell transplantation in patients with AML37.